In vivo breast carcinoma models have shown the effectiveness of antibodies against BTLA in controlling tumor growth and metastasis [213], accompanied by an increase in the number of NKT cells and the expression of cytotoxicity marker genes. Here, BTLA is linked to neoplasm.